Farther Finance Advisors, LLC
Position in FENC — Fennec Pharmaceuticals Inc.
CIK 1992825
SAN FRANCISCO, CA
Position in FENC
as of Sep 30, 2026
· filed Oct 8, 2026
Position Value
$1,171
+$150 QoQ
Shares Held
110
+15.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 3 holders
Holding Since
Sep 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FENC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Sep 30, 2026Farther Finance Advisors, LLC holds $27,307,338 across 327 Biotechnology names. FENC ranks #221 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,471 | $4,951,533 | |
| 2 | MRNA |
Moderna, Inc.
|
17,622 | $3,393,468 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
11,074 | $1,222,569 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,534 | $1,163,186 | |
| 5 | INCY |
Incyte Corp
|
9,256 | $1,123,215 | |
| 6 | EXEL |
Exelixis, Inc.
|
18,290 | $1,068,318 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
4,848 | $995,100 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
12,147 | $795,021 |
All Filings in FENC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $1,171 | 110 | Shares | Sole | 2026-10-08 | |
| 2026-06-30 | $1,021 | 95 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,722 | 280 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,109 | 274 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,564 | 274 | Shares | Sole | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||